Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Dermatology|July 17, 2025
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient-Reported Outcomes in a Randomized TrialJianzhong Zhang, Yangfeng Ding, Ping Wang, et al.
NPJ Aging and Mechanisms of Disease|August 31, 2021
Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging miceSubhashis Banerjee, Sarbani Ghoshal, Clemence Girardet, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb TrialMark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915Carissa S Hampton, Sadichha Sitaula, Cyrielle Billon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2012
NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicologyDavid S Riddick, Xinxin Ding, C Roland Wolf, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
JAMA Dermatology|November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical TrialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
ACS Chemical Biology|March 29, 2023
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise CapacityCyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, et al.
Neurology India|September 20, 2014
Free-access open-source e-learning in comprehensive neurosurgery skills trainingPayal Jotwani, Vinkle Srivastav, Manjul Tripathi, et al.
The Journal of Biological Chemistry|November 19, 2023
Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translationGeetika Aggarwal, Subhashis Banerjee, Spencer A Jones, et al.
Pageof 14